作为激励抗生素研发的一种手段，专利宽限期延长。

Wild-card patent extensions as a means to incentivize research and development of antibiotics.

机构信息

Department of Athletics, Georgetown University, Washington, DC, USA.

出版信息

J Law Med Ethics. 2009 Summer;37(2):240-6. doi: 10.1111/j.1748-720X.2009.00368.x.

DOI:10.1111/j.1748-720X.2009.00368.x

PMID:19493069

Abstract

Antibiotic resistance is a serious public health problem on a global scale. In both developed and developing countries, the unpleasant consequences of the phenomenon are being felt. This paper discusses wild-card patent extensions as a means to incentivize research and development of new antibiotics. The thesis defended in the paper is that the implementation of such patent extensions is an appropriate legislative response to the problem of antibiotic resistance. The general idea of wild-card patent extensions is presented in the first part of the paper. A number of objections to the idea are thereafter discussed and rejected.

摘要

抗生素耐药性是一个全球性的严重公共卫生问题。在发达国家和发展中国家，人们都感受到了这一现象的不良后果。本文探讨了作为激励新抗生素研发的一种手段的“宽领域”专利延期。本文的论点是，实施这种专利延期是对抗生素耐药性问题的一种适当的立法回应。本文的第一部分介绍了“宽领域”专利延期的总体思路。此后，讨论并驳斥了一些对这一想法的反对意见。